DekaBank Deutsche Girozentrale’s Madrigal Pharmaceuticals MDGL Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.03M	Hold	8,000	–	–	0.01%	594
2026 Q1	$4.11M	Hold	8,000	–	–	0.01%	595
2025 Q4	$2.25M	Hold	8,000	–	–	﹤0.01%	745
2025 Q3	$3.51M	Hold	8,000	–	–	0.01%	641
2025 Q2	$2.43M	Hold	8,000	–	–	﹤0.01%	707
2025 Q1	$2.59M	Hold	8,000	–	–	0.01%	687
2024 Q4	$2.47M	Hold	8,000	–	–	﹤0.01%	705
2024 Q3	$1.68M	Hold	8,000	–	–	﹤0.01%	793
2024 Q2	$2.26M	Hold	8,000	–	–	﹤0.01%	740
2024 Q1	$2.06M	Hold	8,000	–	–	﹤0.01%	750
2023 Q4	$1.84M	Hold	8,000	–	–	﹤0.01%	790
2023 Q3	$1.2M	Hold	8,000	–	–	﹤0.01%	846
2023 Q2	$1.76M	Buy	8,000 +2,200	+38%	+$596K	﹤0.01%	777
2023 Q1	$1.35M	Hold	5,800	–	–	﹤0.01%	808
2022 Q4	$1.71M	Buy	+5,800	New	+$567K	﹤0.01%	758
2021 Q3	–	Sell	-25,750	Closed	-$2.49M	–	1405
2021 Q2	$2.49M	Buy	25,750 +12,000	+87%	+$1.42M	0.01%	673
2021 Q1	$1.57M	Buy	13,750 +9,000	+189%	+$1.05M	0.01%	763
2020 Q4	$515K	Buy	+4,750	New	+$581K	﹤0.01%	1015
2019 Q2	–	Sell	-5,850	Closed	-$1.4M	–	1229
2019 Q1	$1.4M	Buy	+5,850	New	+$727K	0.01%	697
2018 Q4	–	Sell	-5,850	Closed	-$1.4M	–	1223
2018 Q3	$1.4M	Sell	5,850 -150	-3%	-$37.6K	0.01%	708
2018 Q2	$1.67M	Buy	+6,000	New	+$1.05M	0.01%	628
2018 Q1	–	Sell	-2	Closed	–	–	1189
2017 Q4	$0	Hold	2	–	–	﹤0.01%	1035
2017 Q3	$0	Hold	2	–	–	﹤0.01%	1046
2017 Q2	$0	Buy	+2	New	+$31	﹤0.01%	1050
2017 Q1	–	Sell	-2	Closed	–	–	991
2016 Q4	$0	Sell	2 -2	-50%	-$32	﹤0.01%	999
2016 Q3	$0	Buy	4 +1	+33%	+$10	﹤0.01%	1000
2016 Q2	$0	Hold	3	–	–	﹤0.01%	1025
2016 Q1	$0	Sell	3 -1,986	-100%	-$16.6K	﹤0.01%	1087
2015 Q4	$24K	Buy	1,989 +58	+3%	+$1.59K	﹤0.01%	1042
2015 Q3	$118K	Buy	1,931 +114	+6%	+$8.23K	﹤0.01%	954
2015 Q2	$142K	Buy	1,817 +357	+24%	+$30K	﹤0.01%	970
2015 Q1	$99K	Sell	1,460 -143	-9%	-$12.3K	﹤0.01%	998
2014 Q4	$146K	Sell	1,603 -143	-8%	-$14.8K	﹤0.01%	890
2014 Q3	$184K	Buy	1,746 +215	+14%	+$29.9K	﹤0.01%	830
2014 Q2	$219K	Buy	1,531 +157	+11%	+$22.9K	﹤0.01%	734
2014 Q1	$207K	Buy	1,374 +28	+2%	+$5.51K	﹤0.01%	717
2013 Q4	$239K	Buy	1,346 +243	+22%	+$44.5K	﹤0.01%	641
2013 Q3	$244K	Buy	+1,103	New	+$235K	﹤0.01%	635

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale's MDGL Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 8,000 shares worth $4.03M. The position accounts for 0.01% of the portfolio, ranked #594.

DekaBank Deutsche Girozentrale first reported a position in MDGL in Q3 2013 and has held it in 38 quarters since. The position peaked at $4.11M in Q1 2026. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

DekaBank Deutsche Girozentrale held 8,000 shares of Madrigal Pharmaceuticals worth $4.03M as of Q2 2026.
DekaBank Deutsche Girozentrale left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
Madrigal Pharmaceuticals made up 0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #594 holding.
DekaBank Deutsche Girozentrale first reported a position in Madrigal Pharmaceuticals in Q3 2013 and has held it in 38 quarters since.
DekaBank Deutsche Girozentrale's Madrigal Pharmaceuticals position peaked at $4.11M in Q1 2026.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.